A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

As the U.S. pulls the funding rug out from under African countries fighting infectious diseases, it is more necessary than ...

The observation also marks a significant step toward a long-awaited universal cancer vaccine to boost the tumor-fighting ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

A review maps high throughput strategies that link automation, microfluidics, and barcoding into a unified pipeline, enabling ...

Lipid nanoparticles (LNPs) have enormous potential for the delivery of genomic medicine. One obstacle, however, is the lack of effective ways to target specific cell types. In order to target lung ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

Researchers from NUS Medicine have developed a novel RNA-based therapy that could transform treatment for metabolic dysfunction-associated steatohepatitis (MASH), previously known as Non-alcoholic ...

Researchers have developed a nanoparticle vaccine that prevented melanoma, pancreatic and triple-negative breast cancer in ...

Chronic inflammation of the liver is a slow, silent disease that can ultimately lead to scarring, cirrhosis, and even liver ...